Nebenwirkungen · Azomyr
Azomyr 5 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 4
HOS-091304 · Präparat HOS-084261
System Organ Class Frequency Adverse reactions seen with Azomyr Metabolism and nutrition Not known Increased appetite disorders Psychiatric disorders Very rare Hallucinations Not known Abnormal behaviour*, aggression*, depressed mood Nervous system disorders Common Headache Very rare Dizziness, somnolence, insomnia, psychomotor hyperactivity, seizures Eye disorders Not known Eye dryness Cardiac disorders Very rare Tachycardia, palpitations Not known QT prolongation* Gastrointestinal disorders Common Dry mouth Very rare Abdominal pain, nausea, vomiting, dyspepsia, diarrhoea Hepatobiliary disorders Very rare Elevations of liver enzymes, increased bilirubin, hepatitis Not known Jaundice Skin and subcutaneous tissue Not known Photosensitivity disorders Musculoskeletal and Very rare Myalgia connective tissue disorders General disorders and Common Fatigue administration site conditions Very rare Hypersensitivity reactions (such as anaphylaxis, angioedema, dyspnoea, pruritus, rash, and urticaria) Not known Asthenia Investigations Not known Weight increased * Undesirable effects reported during the post-marketing period also in paediatric patients.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-03-02T12:10:00Z · SHA-256 bc4fe6f644b260bd790d6c5e828295ca98d7a8c1206535633ac475b1d48c2451 · Passage b1e2cf56770d19b2c55570f0662eb51e173c5bd4b77b8c81e4b47ab1003c786b · Zeichen 872–3320 im Abschnitt